Torrent Pharma Valsartan Recall [US]

US/Silver Spring: Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, recalls all unexpired batch/lots of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/Qhee30lylJS

Direct link: https://www.fda.gov/Safety/Recalls/ucm617821.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

Valsartan Drug Recall Expands [Canada]

Canada/Ottawa: Health Canada expands its recall of various  Valsartan-based drugs due to the suspected presence of N-nitrosodimethylamine (“NDMA”), a potential human carcinogen, and consequential risk of Cancer, all serious health and safety hazards.

HCSC: http://ht.ly/L4HR30lsJFP

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67552a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Valsartan-based Drugs are subject to this recall:

Camber Pharma Valsartan Recall [US]

US/Silver Spring: Camber Pharmaceuticals, Inc., a Piscataway, New Jersey, establishment, recalls all all unexpired batch/lots of Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/klmd30ln4Uq

Direct link: https://www.fda.gov/Safety/Recalls/ucm616405.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

Valsartan Drug Recall [Canada]

Canada/Ottawa: Various pharmaceutical manufacturers have recalled numerous formulations of Valsartan-based drugs due to the presence of N-nitrosodimethylamine (“NDMA”), a potential human carcinogen, and consequential risk of Cancer, all serious health and safety hazards.

HCSC: http://ht.ly/8AUo30l0pu8

Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67202a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Drugs are subject to this recall: